GILEAD SCIENCES, INC.'s Net Worth
-$96.4 Million
Who is GILEAD SCIENCES, INC.?
GILEAD SCIENCES, INC. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arcus Biosciences, Inc., HOOKIPA Pharma Inc., Jounce Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, Allovir, Inc., and ASSEMBLY BIOSCIENCES, INC..
SEC CIK
GILEAD SCIENCES, INC.'s CIK is 0000882095
Past Insider Trading and Trends
2023 was GILEAD SCIENCES, INC.'s most active year for acquiring shares with 2 total transactions. GILEAD SCIENCES, INC.'s most active month to acquire stocks was the month of December. 2006 was GILEAD SCIENCES, INC.'s most active year for disposing of shares, totalling 2 transactions. GILEAD SCIENCES, INC.'s most active month to dispose stocks was the month of September. 2024 saw GILEAD SCIENCES, INC. paying a total of $319,999,995.00 for 15,238,095 shares, this is the most they've acquired in one year. In 2006 GILEAD SCIENCES, INC. cashed out on 8,441,487 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +102.80% | 15.24M |
$21.00 | $319,999,995.00 | 30.06M |
Jan 29
| |||
Form 4
| +7.31% | 1.01M |
$19.26 | $19,452,600.00 | 14.82M |
Jun 28
| |||
Form 4
| +68.38% | 5.65M |
$39.00 | $220,350,000.00 | 13.91M |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HOOKIPA Pharma Inc. (HOOK) Snapshot price: $0.6923
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jounce Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.12M |
—
|
—
| 1.12M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allovir, Inc. (ALVR) Snapshot price: $0.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.39% | 2.93M |
$3.75 | $10,990,762.50 | 16.64M |
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||